Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Press Release

Alzheimer’s disease drug failures plague R&D in neurology, says GlobalData

Despite 2018’s successes in the neurology market, research and development (R&D) setbacks in the field of Alzheimer’s disease continue to disappoint, says GlobalData, a leading data and analytics company.  The Alzheimer’s disease market received major blows when several amyloid targeting β-secretase (BACE) inhibitors dropped out during the year. Merck & Co. terminated verubecestat due to […]
Read more

Female contraceptive market set to be worth $8.7bn by 2027 following the expected release of four new drug candidates, says GlobalData

Contraceptive market sales were estimated to be $6.3bn across the 8MM* in 2017, which is expected to grow to $8.2bn in 2027, at a compound annual growth rate of 2.7%, according to GlobalData, a leading data and analytics company. GlobalData’s report: ‘Contraceptives: Opportunity Analysis and Forecasts to 2027’ states that the launch of four novel contraceptive […]
Read more

Unilever’s acquisition of Graze necessary step to achieving leadership in direct to consumer space, says GlobalData

Following the news of Unilever’s acquisition of Graze, Ronan Stafford, Research Director at GlobalData, offers his view: “Direct to consumer brands have a big future ahead of them, and Unilever’s acquisition of Graze is a necessary step in helping it to achieve leadership in this space. “Last July Unilever stated that direct to consumer accounted […]
Read more

UK could see a dramatic shortfall in skilled workers post-Brexit

The Association of the British Pharmaceutical Industry (ABPI) has warned that the UK is in danger of losing its world-leading research and development status, backed by the country’s two biggest pharma investors, AstraZeneca and GlaxoSmithKline. Gavin Davidson, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “Over the past decade, the […]
Read more
1 … 35 36 37 38 39 … 61